학술논문
2237P Avelumab (AVE), cetuximab (CET) and irinotecan (IRI) for treatment refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): Translational analyses of the AVETUXIRI phase II trial
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S1152-S1152
Subject
Language
ISSN
0923-7534